Vasodilators Global Market Report 2025

Description

Vasodilators are medicines that expand blood vessels by relaxing the smooth muscle cells in vessel walls, particularly in large arteries and veins. They are prescribed to manage conditions such as hypertension (high blood pressure), angina (chest pain), and heart failure, aiming to lessen the heart's workload and enhance circulation.

The primary types of vasodilators include arterial dilators, venous dilators, and mixed dilators. Arterial dilators primarily widen arteries, improving blood flow from the heart throughout the body. Examples of these medications are nitroglycerin, alprostadil, minoxidil, and sorbitrate. They are administered via oral, parenteral, and other routes, and are utilized across various settings including hospitals, homecare, specialty centers, among others.

The vasodilators market research report is one of a series of new reports from The Business Research Company that provides vasodilators market statistics, including vasodilators industry global market size, regional shares, competitors with a vasodilators market share, detailed vasodilators market segments, market trends and opportunities, and any further data you may need to thrive in the vasodilators industry. This vasodilators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The vasodilators market size has grown strongly in recent years. It will grow from $6.4 billion in 2024 to $6.83 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increased awareness and diagnosis, government initiatives and healthcare policies, rising health awareness among the people, advancements in gene therapy, and increasing adoption of artificial intelligence.

The vasodilators market size is expected to see strong growth in the next few years. It will grow to $8.75 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to the rising prevalence of hypertension and cardiovascular diseases, growing demand for advanced medical technology for cardiac diseases, the increasing geriatric population worldwide, the rising prevalence of diabetes and high blood pressure, growing importance of personalized medicine. Major trends in the forecast period include strategic mergers and acquisitions, the shift towards outpatient settings and home-based care, product innovations, technological advancements, and expansion of healthcare infrastructure.

The vasodilators market is poised for growth due to the increasing incidence of cardiovascular diseases. These diseases, which include coronary artery disease, heart failure, and stroke, are often associated with hypertension and other risk factors, fueled by sedentary lifestyles, unhealthy diets, obesity, tobacco use, and aging populations. Vasodilators play a crucial role in managing cardiovascular conditions by relaxing blood vessels, lowering blood pressure, and enhancing blood flow. For instance, in May 2024, the Centers for Disease Control and Prevention (CDC), a US government agency, reported that heart disease caused the deaths of 702,880 individuals in 2022, representing one in every five deaths. Each year in the United States, about 805,000 people suffer a heart attack. Of these, 605,000 are first-time heart attacks, while 200,000 occur in individuals who have experienced a heart attack previously. Hence, the upward trend in cardiovascular diseases is a key driver of the vasodilators market's expansion.

The increasing prevalence of sedentary lifestyles is expected to drive growth in the vasodilators market. Sedentary lifestyles, characterized by limited physical activity and prolonged periods of sitting or lying down, are becoming more common due to modern conveniences such as technology and desk-bound jobs. This trend is fueled by technological advancements and work environments that prioritize convenience over movement. Vasodilators play a crucial role in mitigating cardiovascular risks associated with sedentary lifestyles by improving blood flow and reducing hypertension. For example, data from the Centers for Disease Control and Prevention in September 2023 showed that 22 states in the US had an adult obesity rate of 35% or higher, up from 19 states in 2021, highlighting the growing impact of sedentary lifestyles. This trend is a key driver for the vasodilators market's growth.

Major players in the vasodilators market are concentrating on developing advanced products such as soluble guanylate cyclase (sGC) stimulators to gain a competitive advantage. Soluble guanylate cyclase (sGC) is an enzyme primarily found in cells, particularly in the smooth muscle cells lining blood vessels. Activation of sGC converts guanosine triphosphate (GTP) into cyclic guanosine monophosphate (cGMP), leading to vasodilation and increased blood flow. For instance, in September 2022, Bayer AG, a pharmaceutical and biotechnology company based in Germany, introduced Vericiguat (Verquvo), an sGC stimulator designed for adults with symptomatic chronic heart failure. This drug targets a pathway not addressed by current treatments, thus reducing the risk of cardiovascular death and hospitalization. This strategic focus on innovative products such as sGC stimulators reflects the industry's drive to offer more effective solutions for cardiovascular conditions.

Major companies operating in the vasodilators market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, GlaxoSmithKline Plc., Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., AstraZeneca, Mayo Foundation for Medical Education and Research (MFMER), Boehringer Ingelheim International GmbH, Bayer AG, Viatris Inc., Novo Nordisk A/S, Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen

North America was the largest region in the vasodilators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vasodilators market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the vasodilators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vasodilators market consists of sales of tablets, capsules, injectable solutions, transdermal patches, oral solutions, sublingual tablets, intravenous infusions, topical creams, and gels. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vasodilators Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vasodilators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vasodilators ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vasodilators market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Arterial Dilators; Venous Dilators; Mixed Dilators
2) By Drugs: Nitroglycerin; Alprostadil; Minoxidil; Sorbitrate; Other Drugs
3) By Indication: Hypertension; Angina; Heart Failure; Other Indications
4) By Route Of Administration: Oral; Parenteral; Other Routes Of Administration
5) By End User: Hospitals; Homecare; Specialty Centers; Other End Users
Subsegments:
1) By Arterial Dilators: Calcium Channel Blockers; Nitric Oxide Donors; Potassium Channel Activators
2) By Venous Dilators: Nitrates; Nitrites; Phosphodiesterase Inhibitors (PDE5 Inhibitors)
3) By Mixed Dilators: Alpha-Adrenergic Antagonists; Angiotensin II Receptor Blockers (ARBs); ACE Inhibitors (Angiotensin-Converting Enzyme Inhibitors)
Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG; Sanofi S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r31468

1. Executive Summary

2. Vasodilators Market Characteristics

3. Vasodilators Market Trends And Strategies

4. Vasodilators Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Vasodilators Growth Analysis And Strategic Analysis Framework

5.1. Global Vasodilators PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Vasodilators Market Growth Rate Analysis
5.4. Global Vasodilators Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Vasodilators Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Vasodilators Total Addressable Market (TAM)

6. Vasodilators Market Segmentation

6.1. Global Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Arterial Dilators
Venous Dilators
Mixed Dilators
6.2. Global Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nitroglycerin
Alprostadil
Minoxidil
Sorbitrate
Other Drugs
6.3. Global Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypertension
Angina
Heart Failure
Other Indications
6.4. Global Vasodilators Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Other Route Of Administration
6.5. Global Vasodilators Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Homecare
Speciality Centres
Other End Users
6.6. Global Vasodilators Market, Sub-Segmentation Of Arterial Dilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Calcium Channel Blockers
Nitric Oxide Donors
Potassium Channel Activators
6.7. Global Vasodilators Market, Sub-Segmentation Of Venous Dilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Nitrates
Nitrites
Phosphodiesterase Inhibitors (PDE5 Inhibitors)
6.8. Global Vasodilators Market, Sub-Segmentation Of Mixed Dilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Alpha-Adrenergic Antagonists
Angiotensin II Receptor Blockers (ARBs)
ACE Inhibitors (Angiotensin-Converting Enzyme Inhibitors)

7. Vasodilators Market Regional And Country Analysis

7.1. Global Vasodilators Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Vasodilators Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vasodilators Market

8.1. Asia-Pacific Vasodilators Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vasodilators Market

9.1. China Vasodilators Market Overview
9.2. China Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vasodilators Market

10.1. India Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vasodilators Market

11.1. Japan Vasodilators Market Overview
11.2. Japan Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vasodilators Market

12.1. Australia Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vasodilators Market

13.1. Indonesia Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vasodilators Market

14.1. South Korea Vasodilators Market Overview
14.2. South Korea Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vasodilators Market

15.1. Western Europe Vasodilators Market Overview
15.2. Western Europe Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vasodilators Market

16.1. UK Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vasodilators Market

17.1. Germany Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vasodilators Market

18.1. France Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vasodilators Market

19.1. Italy Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vasodilators Market

20.1. Spain Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vasodilators Market

21.1. Eastern Europe Vasodilators Market Overview
21.2. Eastern Europe Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vasodilators Market

22.1. Russia Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vasodilators Market

23.1. North America Vasodilators Market Overview
23.2. North America Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vasodilators Market

24.1. USA Vasodilators Market Overview
24.2. USA Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vasodilators Market

25.1. Canada Vasodilators Market Overview
25.2. Canada Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vasodilators Market

26.1. South America Vasodilators Market Overview
26.2. South America Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vasodilators Market

27.1. Brazil Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vasodilators Market

28.1. Middle East Vasodilators Market Overview
28.2. Middle East Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vasodilators Market

29.1. Africa Vasodilators Market Overview
29.2. Africa Vasodilators Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Vasodilators Market, Segmentation By Drugs, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Vasodilators Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vasodilators Market Competitive Landscape And Company Profiles

30.1. Vasodilators Market Competitive Landscape
30.2. Vasodilators Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Vasodilators Market Other Major And Innovative Companies

31.1. Bristol-Myers Squibb Company
31.2. Abbott Laboratories
31.3. GlaxoSmithKline Plc.
31.4. Eli Lilly and Company
31.5. Gilead Sciences Inc.
31.6. Amgen Inc.
31.7. AstraZeneca
31.8. Mayo Foundation for Medical Education and Research (MFMER)
31.9. Boehringer Ingelheim International GmbH
31.10. Bayer AG
31.11. Viatris Inc.
31.12. Novo Nordisk A/S
31.13. Teva Pharmaceutical Industries Ltd.
31.14. Astellas Pharma Inc.
31.15. Biogen

32. Global Vasodilators Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vasodilators Market

34. Recent Developments In The Vasodilators Market

35. Vasodilators Market High Potential Countries, Segments and Strategies

35.1 Vasodilators Market In 2029 - Countries Offering Most New Opportunities
35.2 Vasodilators Market In 2029 - Segments Offering Most New Opportunities
35.3 Vasodilators Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer